Pierre-Etienne Heudel - JoVE Visualize

Showing results (31-40 of 56) with videos related to

Pageof 6

Sort By:

Anticancer Research|July 5, 2020

GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian CancerFrÉdÉric Selle, Pierre-Etienne Heudel, Anne-Claire Hardy-Bessard, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 2021

Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and NumberLaurie Besson, Benoite Mery, Magali Morelle, et al.

International Journal of Clinical Oncology|June 6, 2021

Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer centerPierre-Etienne Heudel, Béatrice Fervers, Thierry Durand, et al.

Cancers|April 3, 2021

Patterns of Sequelae in Women with a History of Localized Breast Cancer: Results from the French VICAN SurveyLidia Delrieu, Liacine Bouaoun, Douae El Fatouhi, et al.

Plos One|February 4, 2017

Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)Olfa Derbel, Pierre Etienne Heudel, Claire Cropet, et al.

International Journal of Clinical Oncology|August 13, 2013

Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes regionPierre Etienne Heudel, Philippe Cousin, Antoine Lurkin, et al.

Breast Cancer (Dove Medical Press)|May 4, 2023

Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective StudyBenoîte Mery, Christine Ménétrier-Caux, Laure Montané, et al.

JAMA Oncology|October 8, 2020

Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical TrialIsabelle Ray-Coquard, Philipp Harter, Domenica Lorusso, et al.

Cell Reports. Medicine|January 10, 2026

Molecular and cellular composition changes after neoadjuvant letrozole and palbociclib in early luminal breast cancerPaul Cottu, Yann Kieffer, Jerome Lemonnier, et al.

Gynecologic Oncology|July 1, 2025

NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancerKristina Lindemann, Dominique Berton, Jalid Sehouli, et al.

Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:

Pageof 6

Anticancer Research|July 5, 2020

GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian CancerFrÉdÉric Selle, Pierre-Etienne Heudel, Anne-Claire Hardy-Bessard, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 2021

Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and NumberLaurie Besson, Benoite Mery, Magali Morelle, et al.

International Journal of Clinical Oncology|June 6, 2021

Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer centerPierre-Etienne Heudel, Béatrice Fervers, Thierry Durand, et al.

Cancers|April 3, 2021

Patterns of Sequelae in Women with a History of Localized Breast Cancer: Results from the French VICAN SurveyLidia Delrieu, Liacine Bouaoun, Douae El Fatouhi, et al.

Plos One|February 4, 2017

Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)Olfa Derbel, Pierre Etienne Heudel, Claire Cropet, et al.

International Journal of Clinical Oncology|August 13, 2013

Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes regionPierre Etienne Heudel, Philippe Cousin, Antoine Lurkin, et al.

Breast Cancer (Dove Medical Press)|May 4, 2023

Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective StudyBenoîte Mery, Christine Ménétrier-Caux, Laure Montané, et al.

JAMA Oncology|October 8, 2020

Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical TrialIsabelle Ray-Coquard, Philipp Harter, Domenica Lorusso, et al.

Cell Reports. Medicine|January 10, 2026

Molecular and cellular composition changes after neoadjuvant letrozole and palbociclib in early luminal breast cancerPaul Cottu, Yann Kieffer, Jerome Lemonnier, et al.

Gynecologic Oncology|July 1, 2025

NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancerKristina Lindemann, Dominique Berton, Jalid Sehouli, et al.

Pageof 6